TOCILIZUMAB

71748 reported adverse events

Drug classes: Interleukin-6 Receptor Antagonist [EPC]

These side effects are most commonly reported by patients taking TOCILIZUMAB:

# Side effect Count
0 DRUG INEFFECTIVE 26438
1 RHEUMATOID ARTHRITIS 15536
2 PAIN 12606
3 OFF LABEL USE 10236
4 ARTHRALGIA 9825
5 JOINT SWELLING 9320
6 FATIGUE 8783
7 DRUG INTOLERANCE 8380
8 RASH 7976
9 CONTRAINDICATED PRODUCT ADMINISTERED 7719
See all common reactions for TOCILIZUMAB

TOCILIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 271 0.9313
1 RED BLOOD CELL SEDIMENTATION RATE 161 0.8944
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2276 0.8811
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 61 0.8714
4 DISABILITY ASSESSMENT SCALE SCORE INCREASED 181 0.8660
5 SWOLLEN JOINT COUNT INCREASED 428 0.8376
6 PEMPHIGUS 4462 0.8312
7 RHEUMATOID FACTOR NEGATIVE 131 0.7988
8 RHEUMATOID FACTOR POSITIVE 2009 0.7820
9 RHEUMATIC FEVER 522 0.7791
See all enriched reactions for TOCILIZUMAB